
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services is supported by a favorable mix of scale, margin, and growth catalysts, with behavioral health generating just over half of consolidated operating income and over 55% of pretax profits despite acute care representing more than 55% of revenue. The company’s 1Q26 consolidated adjusted EBITDA rose 8.4% year over year, helped by pricing strength and higher acuity mix, while behavioral health posted same-store revenue growth of 7.3% and adjusted EBITDA growth of 8% amid moderating labor pressure. Its positive outlook also reflects continued capacity expansion, potential upside from state directed payment programs and Florida approvals, and a disciplined capital plan including $800-900m in share repurchases and the Talkspace acquisition.
Bears say
Universal Health Services is facing a negative fundamental setup because its business mix leaves it exposed to sluggish acute care volumes and margin pressure, while more profitable behavioral health operations are vulnerable to tight state budgets and regulatory shifts. Concentration risk in Nevada, Texas, and California heightens earnings volatility, and the 2020 cyberattack showed how operational disruptions can carry meaningful financial cost, with an estimated $67MM pre-tax impact. On top of that, a possible Medicare-For-All or ACA repeal-and-replace framework, tighter clinical labor supply, and reimbursement pressure could keep FY27 earnings about 5% below estimates and compress valuation multiples.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares